Treatment of visceral aneurysm using multilayer stent: two-year follow-up results in five consecutive patients.
Cardiovasc Intervent Radiol
; 36(5): 1256-61, 2013 Oct.
Article
en En
| MEDLINE
| ID: mdl-23934113
ABSTRACT
PURPOSE:
The present study was performed to analyze the midterm results (five consecutive patients, 2-year follow-up) of the endovascular management of visceral artery aneurysms using the Cardiatis Multilayer Flow Modulator (CMFM) (Cardiatis, Isnes, Belgium), a self-expandable stent. MATERIALS ANDMETHODS:
From August 2009 to January 2011, we implanted five CMFMs in five patients (all men; mean age 73 years) to treat two common hepatic artery aneurysms, one celiac trunk aneurysm, one splenic artery aneurysm, and one superior mesenteric artery aneurysm (diameter 25-81 mm). The primary end point was technical success. The secondary end point was stent patency, absence of aneurysm rupture or reperfusion, and shrinking of the sac at 6-, 12-, and 24-month follow-up using computed tomography angiography. Follow-up ranged from 24 to 48 months (mean 31.2).RESULTS:
Technical success was achieved in all patients. Complete exclusion of the aneurysm with sac shrinking was achieved in two patients. Two stents became occluded at 6- and 24-month follow-up, respectively; both patients were asymptomatic and were not retreated. One patient developed sac reperfusion due to incomplete aneurysm exclusion.CONCLUSION:
Long-term results in a wider population are needed to validate the effectiveness of the CMFM.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Arteria Esplénica
/
Arteria Celíaca
/
Stents
/
Arteria Mesentérica Superior
/
Arteria Hepática
/
Aneurisma
Tipo de estudio:
Observational_studies
/
Prognostic_studies
Idioma:
En
Revista:
Cardiovasc Intervent Radiol
Año:
2013
Tipo del documento:
Article